Study #PA19-0095
Accessing Serum Markers to Link the Emergence of Immune Toxicities and Effectiveness of Remedies in GU Cancer Patients Treated with Immunotherapies
MD Anderson Study Status
Enrolling
Treatment Agent
Description
IO Tox Remote Intervention
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Pavlos Msaouel
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-855-500-5942
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.